SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 424B5 - Prospectus [Rule 424(b)(5)]:
SEC Accession No. 0001193125-21-169353
Filing Date
2021-05-21
Accepted
2021-05-21 16:38:41
Documents
3

Document Format Files

Seq Description Document Type Size
1 424B5 d185787d424b5.htm 424B5 282673
2 GRAPHIC g185787g24p94.jpg GRAPHIC 44440
3 GRAPHIC g185787g79j32.jpg GRAPHIC 42714
  Complete submission text file 0001193125-21-169353.txt   392658
Mailing Address 200 SIDNEY STREET CAMBRIDGE MA 02139
Business Address 200 SIDNEY STREET CAMBRIDGE MA 02139 617 945 9626
Seres Therapeutics, Inc. (Filer) CIK: 0001609809 (see all company filings)

IRS No.: 274326290 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 424B5 | Act: 33 | File No.: 333-244401 | Film No.: 21949648
SIC: 2834 Pharmaceutical Preparations